Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
687
datasets available to search
ShareScore release 0.9.0
Dataset results
687 results for “MDS”
STIMULUS MDS-US : Sabatolimab Added to HMA in Higher Risk MDS
ClinicalTrials.gov study NCT04878432. IPD Sharing: YES. Countries: 1. Publications: 0.
Ruxolitinib for Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01895842. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of KB004 in Subjects With Hematologic Malignancies (Myelodysplastic Syndrome, MDS, Myelofibrosis, MF)
ClinicalTrials.gov study NCT01211691. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Omacetaxine + Azacitidine in Untreated Patients With High Grade MDS
ClinicalTrials.gov study NCT03564873. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Determination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT00303472. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Clinical Trial of BP1001 (L-Grb-2 Antisense Oligonucleotide) in CML, AML, ALL & MDS
ClinicalTrials.gov study NCT01159028. IPD Sharing: Not stated. Countries: 1. Publications: 1.
GENOMED4ALL: Improving MDS Classification and Prognosis by AI
ClinicalTrials.gov study NCT04889729. IPD Sharing: Not stated. Countries: 1. Publications: 33.
Transfusion in Lower Risk MDS Patients: Predictors of Adequacy of Transfusion and Quality of Life in Lower Risk MDS
ClinicalTrials.gov study NCT06614595. IPD Sharing: NO. Countries: 1. Publications: 2.
Treatment of Imminent Haematological Relapse in Patients With AML and MDS Following Allogeneic Stem Cell Transplantation With 5-azacitidine (Vidaza®)
ClinicalTrials.gov study NCT00422890. IPD Sharing: Not stated. Countries: 1. Publications: 1.
SRSF2 Gene Mutation in Patients With t-MDS/AML
ClinicalTrials.gov study NCT03894852. IPD Sharing: Not stated. Countries: 1. Publications: 12.
Assessment of Body, Liver and Labile Plasma Iron and Their Association With Outcome and Immunological Recovery in Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Patients Undergoing All
ClinicalTrials.gov study NCT01746147. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Oral Rigosertib in Low Risk MDS Patients Refractory to ESAs
ClinicalTrials.gov study NCT01904682. IPD Sharing: Not stated. Countries: 3. Publications: 2.
Ascorbic Acid Levels in MDS, AML, and CMML Patients
ClinicalTrials.gov study NCT03526666. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMML
ClinicalTrials.gov study NCT05641259. IPD Sharing: NO. Countries: 1. Publications: 3.
ASTX727 and Donor Lymphocyte Infusions After Allogenic Stem Cell Transplantation in Very High Risk MDS or AML Patients
ClinicalTrials.gov study NCT04857645. IPD Sharing: NO. Countries: 1. Publications: 1.
Study With Azacitidine in Pediatric Subjects With Newly Diagnosed Advanced Myelodysplastic Syndrome (MDS) and Juvenile Myelomonocytic Leukemia (JMML)
ClinicalTrials.gov study NCT02447666. IPD Sharing: Not stated. Countries: 13. Publications: 1.
Three Dosing Schedules of Oral Rigosertib in MDS Patients
ClinicalTrials.gov study NCT02075034. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA
ClinicalTrials.gov study NCT02562443. IPD Sharing: Not stated. Countries: 22. Publications: 3.
A Phase Ib Study of Panobinostat (LBH589) in Combination With 5-Azacitidine for Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) Patients
ClinicalTrials.gov study NCT01613976. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of 5-day Dosing of ON 01910.Na in Intermediate-1,-2, or High Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00867061. IPD Sharing: Not stated. Countries: 1. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.